Alejandro Olivares Hernández-rekin lankidetzan egindako argitalpenak (14)

2024

  1. Diagnóstico nosológico y de extensión. Factores pronósticos

    Oncología clínica (Arán), pp. 59-71

  2. Tumores de origen desconocido

    Oncología clínica (Arán), pp. 407-418

2023

  1. Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis

    Chinese Clinical Oncology, Vol. 12, Núm. 6

  2. Uso de anakinra en el tratamiento de la infección respiratoria grave por SARS-CoV-2

    Reumatologia clinica, Vol. 19, Núm. 2, pp. 121

2022

  1. Acute esophageal necrosis induced by immune checkpoint inhibitors

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 3, pp. 182-183

  2. Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88

  3. Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis

    Biomedicines, Vol. 10, Núm. 2

2021

  1. Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab

    Reumatologia Clinica, Vol. 17, Núm. 10, pp. 559-561

  2. Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications

    Biomolecules, Vol. 11, Núm. 2, pp. 1-16

  3. Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors

    Life, Vol. 11, Núm. 12

  4. Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  5. The influence of diet and probiotics on the response of solid tumours to immunotherapy: Present and future perspectives

    Applied Sciences (Switzerland), Vol. 11, Núm. 18

2020

  1. Management of Febrile Neutropenia Associated with SARS-CoV-2 Infection in a Patient with Cancer

    JCO Oncology Practice

  2. Reply to A. Lasagna et al

    JCO Oncology Practice